Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2012
09/26/2012CN101940625B Preparation method and use of extract
09/26/2012CN101912485B Medicinal composition having functions of resisting inflammation and easing pain and preparation method and application thereof
09/26/2012CN101704766B Preparation method of arginine aspirin and powder-injection of arginine aspirin
09/26/2012CN101612173B Glabrous sarcandra herb extract, quality control method for extract preparation and application of thereof
09/26/2012CN101611015B Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders
09/26/2012CN101558877B Teabag containing paeoniifolia for clearing heat, reducing pathogenic fire, resisting bacterium and diminishing inflammation and manufacturing method thereof
09/26/2012CN101248087B Improved nanobodies(tm) against tumor necrosis factor-alpha
09/25/2012US8273895 NK1 antagonists
09/25/2012US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/25/2012US8273360 Neisseria membrane protein mixture for use in developing vaccine to prevent bacterial infection; bactericides; immunotherapy
09/25/2012US8273350 Antibodies to human IL-1β
09/25/2012CA2683040C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
09/25/2012CA2667481C New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
09/25/2012CA2667285C New sulfonamide derivatives as bradykinin antagonists
09/25/2012CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
09/25/2012CA2496688C Glycinamide derivatives as raf-kinase inhibitors
09/25/2012CA2453295C Novel oligoribonucleotide derivatives for specific inhibition of gene expression
09/25/2012CA2189778C Use of fas ligand to suppress lymphocyte-mediated immune responses
09/20/2012WO2012125942A1 Combination therapy with leukotoxin
09/20/2012WO2012125893A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
09/20/2012WO2012125887A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
09/20/2012WO2012125886A1 Pyrrolopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
09/20/2012WO2012125871A2 Aconitine compounds, compositions, uses, and preparation thereof
09/20/2012WO2012125749A2 INFLAMMATION AND AUTOIMMUNE DISORDER TREATMENT USING RARα SELECTIVE AGONISTS
09/20/2012WO2012125629A1 Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
09/20/2012WO2012125613A1 Morpholine-spirocyclic piperidine amides as modulators of ion channels
09/20/2012WO2012125598A1 Benzodioxane inhibitors of leukotriene production
09/20/2012WO2012125544A2 Necroptosis inhibitors and methods of use therefor
09/20/2012WO2012125471A1 Methods and compositions relating to mesenchymal stem cell exosomes
09/20/2012WO2012125305A1 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012WO2012123522A1 6,5-heterocyclic propargylic alcohol compounds and uses therefor
09/20/2012WO2012123381A1 Use of low dose il-2 for treating autoimmune - related or inflammatory disorders
09/20/2012WO2012123312A1 Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
09/20/2012WO2012122931A1 Paecilomyces tenuipes strain and applications thereof
09/20/2012WO2012122707A1 Quaternary ammonium salt compounds, preparation method, pharmaceutical composition and use thereof
09/20/2012WO2012099447A3 Transgenic pig expressing stnfr1-fc genes and the use thereof
09/20/2012WO2012097173A3 Substituted benzoazepines as toll-like receptor modulators
09/20/2012WO2012089175A3 Traditional chinese medicinal tea made by microbial fermentation method
09/20/2012WO2011005295A8 Modulators of the sphingosine-1-phosphate (s1p) receptor useful for the treatment of disorders related thereto
09/20/2012US20120238940 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
09/20/2012US20120238642 Polymer Mechanical Damping Composites and Methods of Production
09/20/2012US20120238634 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators
09/20/2012US20120238630 Compositions comprising nonsteroidal anti - inflammatory drugs
09/20/2012US20120238628 Dihydronaphthalene and naphthalene derivatives as n-formyl peptide receptor like-1 (fprl-1) receptor modulators
09/20/2012US20120238625 Biologically active oils
09/20/2012US20120238624 Formulations for the treatment of pain
09/20/2012US20120238623 Inflammation and Autoimmune Disorder Treatment using RARa Selective Agonists
09/20/2012US20120238615 Alpha adrenergic receptor modulators
09/20/2012US20120238613 Sec-hydroxycyclohexyl derivatives
09/20/2012US20120238611 Dual-acting benzoimidazole antihypertensive agents
09/20/2012US20120238610 Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
09/20/2012US20120238599 Heterocyclic compounds as mek inhibitors
09/20/2012US20120238594 Azaspirodecanone compounds
09/20/2012US20120238593 Heterocyclic compounds and uses thereof
09/20/2012US20120238587 Novel pyridopyrimidine derivatives and use thereof
09/20/2012US20120238586 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238585 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238582 Quinazoline derivatives
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238576 Triazine Derivatives and their Therapeutical Applications
09/20/2012US20120238571 Indazole derivatives as pi 3-kinase
09/20/2012US20120238567 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
09/20/2012US20120238565 Triazolopyridine compounds and their use as ask inhibitors
09/20/2012US20120238561 Morpholinothiazoles as alpha 7 positive allosteric modulators
09/20/2012US20120238559 Novel compounds
09/20/2012US20120238553 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
09/20/2012US20120238551 Substituted Phenoxypropylcycloamine Derivatives as Histamine-3 (H3) Receptor Ligands
09/20/2012US20120238549 Nuclear Hormone Receptor Modulators
09/20/2012US20120238548 1,4-oxazepines as bace1 and/or bace2 inhibitors
09/20/2012US20120238547 2, 3, 6 - triamino substituted pyridines as kv7 (kcnq) channel modulators
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238544 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
09/20/2012US20120238540 Amino-pyrimidine compounds as inhibitors of ikk epsilon and/or tbk1
09/20/2012US20120238534 Oral suspension of prednisolone acetate
09/20/2012US20120238530 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238528 Novel phosphonic acid compounds as inhibitors of serine proteases
09/20/2012US20120238526 Aconitine compounds, compositions, uses, and preparation thereof
09/20/2012US20120238520 Novel Medical Use
09/20/2012US20120238519 Ophthalmic composition containing alginic acid or salt thereof
09/20/2012US20120238513 Method for inhibiting activation of macrophages
09/20/2012US20120238501 Modulation Of Osteoclast Differentiation
09/20/2012US20120237619 Combretum laurifolium mart. extract and methods of extracting and using such extract
09/20/2012US20120237618 Formulations, devices and methods for treating and preventing mucositis
09/20/2012US20120237617 Use of nitrite salts in treating tissue damage
09/20/2012US20120237602 Press-coated orally-disintegrating tablets
09/20/2012US20120237601 Pharmaceutical Compositions Comprising Mycophenolic Acid or Mycophenolate Salt
09/20/2012US20120237596 Nutrient delivery drug composition
09/20/2012US20120237593 Formulations of Guanylate Cyclase C Agonists and Methods of Use
09/20/2012US20120237587 Combination preparation including a corticosteroid and exosomes
09/20/2012US20120237566 Inhibiting stomach-acid release, reducing inflammation and preventing and treating cancer: compositions and methods of use
09/20/2012US20120237565 Pegylated polyplexes containing two or more different polymers for polynucleotide delivery
09/20/2012US20120237563 Controlled-release formulations of anabaseine compounds and uses thereof
09/20/2012US20120237559 Formulations and methods for treating rhinosinusitis
09/20/2012US20120237556 Topical base and active agent-containing compositions, and methods for improving and treating skin
09/20/2012US20120237552 Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments
09/20/2012US20120237525 Combination preparation including a cytokine antagonist and corticosteroid
09/20/2012US20120237516 Compositions and methods relating to anti-igf-1 receptor antibodies
09/20/2012US20120237514 Vascular endothelial cell growth factor antagonists and uses thereof
09/20/2012US20120237510 Anti-NKG2A Antibodies and Uses Thereof
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 1272